GU Cancers 2020 | Translational approaches in immunotherapy

Name: Translational approaches in immunotherapy
Uploaded: 2020-02-15T00:00:00.000Z
Duration: 2 min 41 s
Description: Ziad Bakouny, MD, Dana-Farber Cancer Institute, Boston, MA, gives his thoughts on the translational approaches in immunotherapy for renal cell carcinoma (RCC). Specifically, he focuses on the potential of single-cell sequencing methods and other modalities for discovery. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Ziad Bakouny • 15 Feb 2020

GU Cancers 2020

Genitourinary Cancer Kidney Cancer Checkpoint Inhibitors

Ziad Bakouny, MD, Dana-Farber Cancer Institute, Boston, MA, gives his thoughts on the translational approaches in immunotherapy for renal cell carcinoma (RCC). Specifically, he focuses on the potential of single-cell sequencing methods and other modalities for discovery. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.